White Marvin L
SEC CIK 1493324 · EDGAR
BoughtSold
Most active insiders at APVO, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Grant Grady III | Dir | $20.1K | — |
| 2 | Kwon SoYoung | SVP, GC, BD, Corp Affairs | — | — |
| 3 | Huebner Dirk | SVP, CMO | — | — |
| 4 | Kunz Barbara Lopez | Dir | — | — |
| 5 | Lamothe Jeffrey G. | Pres, CEO, Dir | — | — |
| 6 | Niederhuber John | Dir | — | — |
| 7 | White Marvin L | Executive COB, Dir | — | — |
| 8 | Taylor Daphne | SVP, CFO | — | — |
| 9 | Abdun-Nabi Daniel | Dir | — | — |
| 10 | Harsanyi Zsolt | Dir | — | — |
Transactions 15
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-08-10 21:34 | 2026-07-17+ | APVO | Aptevo Therapeutics Inc. | White Marvin L | Executive COB, Dir | M - OptEx | — | +1,667 | 1,667 | New | — |
| D | 2026-08-10 21:34 | 2026-08-06 | APVO | Aptevo Therapeutics Inc. | White Marvin L | Executive COB, Dir | F - Tax | $4.07 | -406 | 1,261 | -24% | -$1,652 |
| D | 2026-05-04 17:29 | 2026-04-30 | EBS | Emergent BioSolutions Inc. | White Marvin L | Dir | A - Grant | $0.00 | +25.3K | 113.8K | +29% | $0 |
| D | 2025-07-21 | 2025-07-17 | APVO | Aptevo Therapeutics Inc. | White Marvin L | Pres, CEO, Dir | M - OptEx | — | +10 | 12 | +500% | — |
| D | 2025-05-02 | 2025-04-30 | EBS | Emergent BioSolutions Inc. | White Marvin L | Dir | A - Grant | $0.00 | +34.4K | 88.5K | +64% | $0 |
| DM | 2025-03-04 | 2025-03-02+ | APVO | Aptevo Therapeutics Inc. | White Marvin L | Pres, CEO, Dir | M - OptEx | — | +14 | 55 | +34% | — |
| 2024-11-13 | 2024-11-11 | EBS | Emergent BioSolutions Inc. | White Marvin L | Dir | S - Sale | $11.97 | -14.3K | 54.1K | -21% | -$171.0K | |
| D | 2024-05-28 | 2024-05-23 | EBS | Emergent BioSolutions Inc. | White Marvin L | Dir | A - Grant | $0.00 | +17.4K | 68.4K | +34% | $0 |
| DM | 2024-03-05 | 2024-03-02+ | APVO | Aptevo Therapeutics Inc. | White Marvin L | Pres, CEO, Dir | M - OptEx | — | +22.5K | 67.4K | +50% | — |
| D | 2024-01-30 | 2024-01-28 | APVO | Aptevo Therapeutics Inc. | White Marvin L | Pres, CEO, Dir | M - OptEx | — | +4,792 | 44.9K | +12% | — |
| 2023-05-30 | 2023-05-25 | EBS | Emergent BioSolutions Inc. | White Marvin L | Dir | A - Grant | $0.00 | +33.8K | 50.9K | +198% | $0 | |
| D | 2023-03-07 | 2023-03-03 | APVO | Aptevo Therapeutics Inc. | White Marvin L | Pres, CEO, Dir | M - OptEx | — | +9,582 | 40.1K | +31% | — |
| D | 2023-01-30 | 2023-01-29 | APVO | Aptevo Therapeutics Inc. | White Marvin L | Pres, CEO, Dir | M - OptEx | — | +4,791 | 30.6K | +19% | — |
| 2022-05-31 | 2022-05-26 | EBS | Emergent BioSolutions Inc. | White Marvin L | Dir | A - Grant | $0.00 | +8,446 | 17.1K | +98% | $0 | |
| D | 2022-02-01 | 2022-01-29 | APVO | Aptevo Therapeutics Inc. | White Marvin L | Pres, CEO, Dir | M - OptEx | — | +4,792 | 25.8K | +23% | — |
Purchase Sale Sale after option exercise All abbreviations